Key facts
- Notable investors include Hefei Industry Investment Group.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Apogenomics
- ·The full record, as it builds
Funding rounds
No funding rounds for Apogenomics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Apogenomics
Developer of non-invasive molecular diagnostic technologies focused on overcoming key limitations in cfDNA testing through patented innovations. The company offers cfDNA detection kits, background noise suppression tools, sensitivity enhancement algorithms, clinical diagnostic software, bioinformatics pipelines, molecular analysis modules and research support services, thereby enabling more accurate, scalable, and efficient diagnostics for clinical and research applications.
- Sector
- Healthcare
- HQ
- Hefei, Cuba
- Founded
- 2024
- Website
- apogenomics.com/
- Ownership
- Privately Held (backing)
Apogenomics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Apogenomics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Apogenomics in its N-PORT filings yet. We sweep new filings monthly.